The Valley Desk

NCT02592798 · Interventional trial

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

Overall registry status Completed

Phase 2

Conditions Focal Segmental Glomerulosclerosis, Minimal Change Disease, Nephrotic Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov